Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > GXDX > Summary

Genoptix, Inc.
(GXDX)

31.34USD   Up0.09 (0.29%)   
At 2:30AM IST
 Genoptix, Inc. (NasdaqNM:GXDX) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 31.34USD
Trade Time:2:30AM IST
Change:Up0.09 (0.29%)
Prev Close:31.25
Open:31.35
Bid:30.49 x 200
Ask:32.19 x 200
1y Target Est:41.43
Day's Range:31.13 - 31.77
52wk Range:24.15 - 38.13
Volume:138,502
Avg Vol (3m):219,994
Market Cap:537.92M
P/E (ttm):19.55
EPS (ttm):1.60
Div & Yield:N/A (N/A%)
Add GXDX to Portfolio   Download Data

HEADLINES

 
•Genoptix, Momenta Shares Headed for Gains - TheStreet.com  - Tue 3:30PM
•Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results - PR Newswire  - Thu, Feb 4
•[$$] Pericom, PetroQuest, Kulicke & Soffa Jump - The Wall Street Journal Online  - Tue, Feb 2
•[$$] Russell 2000 Closes Out January With a Decline of 1% - The Wall Street Journal Online  - Sat, Jan 30
•Genoptix Announces Participation at Jefferies 2010 Global Healthcare Services Conference - PR Newswire  - Tue, Jan 19
•GENOPTIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement - EDGAR Online  - Fri, Jan 15
•GENOPTIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement - EDGAR Online  - Sat, Jan 9
•Genoptix Announces Participation at 28th Annual J.P. Morgan Healthcare Conference - PR Newswire  - Mon, Jan 4
•Genoptix Enters Oversold Territory - Zacks.com  - Thu, Dec 31
•Build Your Fortune With These Winners - Motley Fool  - Thu, Dec 24
•GENOPTIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits - EDGAR Online  - Wed, Dec 23
» More Headlines for GXDX...

ANALYST

 
EPS Est (next year) (Dec-09) :1.65
EPS Est (in 2 years) (Dec-10) :1.90
Avg Rec (current)*:1.7
PEG Ratio:0.83
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Genoptix, Inc. provides specialized laboratory service that focus on delivering diagnostic services in the United States. Its services include COMPASS service offering, in which the company’s hematopathologists determine the appropriate diagn...

» Full Company Profile